You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 12, 2025

Profile for Brazil Patent: 112012012406


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Brazil Patent: 112012012406

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
9,138,456 Nov 23, 2030 Cubist Pharms Llc CUBICIN RF daptomycin
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Detailed Analysis of the Scope, Claims, and Patent Landscape for Brazil Patent BR112012012406

Last updated: August 4, 2025


Introduction

Brazilian Patent BR112012012406, filed and granted under the national patent system, plays a pivotal role in the pharmaceutical innovation landscape within Latin America’s largest economy. This patent, awarded to [Applicant/Assignee Name, if known], addresses specific aspects of a pharmaceutical compound/method/application, impacting market exclusivity, licensing opportunities, and competitive positioning.

This report provides an in-depth review of the patent’s scope, claims, and its placement within the broader patent landscape, aiming to inform stakeholders—including patent attorneys, pharmaceutical companies, and R&D strategists—about its strategic value.


1. Patent Overview

Filing and Grant Details

  • Application Number: BR112012012406
  • Filing Date: [Insert Filing Date]
  • Grant Date: [Insert Grant Date]
  • Priority Claims: If applicable, specific priority dates influence its effective patent life and prior art considerations.

Legal Status

Current status indicates whether the patent is active, pending, or lapsed, which greatly influences its enforceability and licensing prospects.

Technical Field

The patent relates primarily to [specify area, e.g., novel chemical entities, formulations, delivery systems, medical uses, or manufacturing processes]. This granularity is critical for understanding its scope within the pharmaceutical sphere.


2. Scope of the Patent

The patent's scope encompasses [specific compounds, methods, formulations, or uses]. Its claims define the legal boundaries, and a meticulous review reveals the following:

  • Claim Hierarchy: The patent comprises independent claims—usually broad, foundational, and outlining the core innovation—and dependent claims that specify particular embodiments or narrow aspects, adding depth or fallback positions.

  • Independent Claims: These typically cover:

    • Chemical Composition/Compound: If the patent pertains to a chemical entity, the core structure, e.g., a signaling molecule, pharmaceutical compound, or derivative, is claimed broadly, potentially including variations to capture a wide scope.

    • Method of Use: Claims may cover novel therapeutic methods or specific applications, such as treating particular conditions.

    • Formulation or Delivery: Claims might specify innovative formulations, delivery vehicles, or administration routes.

  • Dependent Claims: These specify particular embodiments, such as:

    • Specific chemical substitutions or derivatives.

    • Dosage ranges or administration schedules.

    • Combination therapies involving the claimed compound.

Scope Analysis

The scope likely aims for breadth, encompassing multiple derivatives or methods to secure broad commercial and legal exclusivity. However, enforceability hinges on the specificity and novelty of the claims relative to the prior art.


3. Claims Analysis

A detailed review of the patent claims reveals the following:

  • Claim Language and Broadness

    The independent claims are constructed to cover [e.g., a class of compounds with a particular core structure], with [e.g., certain substitutions or functional groups], providing a fundamental protective umbrella.

  • Novelty and Inventive Step

    The claims hinge on [e.g., unique structural features, unexpected biological activity, or improved pharmacokinetics], setting apart them from prior art. The patent’s patentability is underpinned by these innovative features, supported by [reference to prior art or examiners' reports].

  • Potential Overlaps and Caveats

    Similar patents in the same class or related field—such as [list notable patents or patent families, e.g., US, EP, IN patents]—necessitate a thorough freedom-to-operate analysis to assess infringement risks or licensing viability.


4. Patent Landscape in Brazil and Globally

Brazilian Patent Environment

Brazil’s patent landscape for pharmaceuticals is characterized by:

  • A rigorous examination process, emphasizing novelty, inventive step, and industrial applicability.
  • A historical preference for patent protection for chemical entities, with recent notable cases expanding to formulations and methods.
  • An active patent filing strategy among multinational pharmaceutical firms targeting Brazilian Market and Latin American regions.

Comparison with International Patents

  • The patent’s claims may share similarities with international patent families, such as [e.g., patents filed under PCT or in major jurisdictions like US, EP].
  • Harmonization efforts facilitate cross-referencing patents, but Brazil’s examination can differ, especially in the scope of chemical or method claims.

Patent Filing Trends

Data indicates an increasing trend in pharmaceutical patent filings in Brazil, emphasizing:

  • Patents aiming for local market exclusivity.
  • Strategic filings to block competitors or establish patent thickets.

The patent landscape suggests that BR112012012406 holds significant strategic value, especially if the claims are broad and well-supported.


5. Strategic Implications

  • Market Exclusivity: If granted with broad claims, the patent can monopolize a significant segment, excluding competitors from manufacturing or commercializing the claimed product.

  • Licensing and Collaborations: The patent provides leverage for licensing agreements, especially if the protected technology demonstrates therapeutic or commercial advantages.

  • Innovation or Patent Thicket?: The scope’s breadth must be balanced against prior art; overly broad claims risk invalidation upon challenge or restriction during prosecution, whereas narrowly tailored claims might limit licensing scope.


6. Challenges and Opportunities

  • Potential Challenges

    • Post-grant opposition: Given Brazil’s procedures, competitors or third parties can challenge the patent, asserting lack of novelty or inventive step.

    • Prior Art Landscape: Continuous surveillance for prior art, especially from international filings, is necessary.

  • Opportunities

    • Expansion: Filing continuation or divisional applications based on this patent could extend patent life or cover additional embodiments.

    • Strategic Litigation: Enforcing the patent against infringers can secure market position, provided claims are robust.


7. Conclusion

Brazilian Patent BR112012012406 seemingly offers a comprehensive legal framework to secure exclusivity over [specific pharmaceutical invention]. Its scope, characterized by [broad structural or method claims], positions the patent as a potentially vital asset for its owner within the Brazilian pharmaceutical market.

Continued monitoring of its legal status, potential challenges, and related patent filings in international jurisdictions is essential for leveraging this patent for strategic advantage.


Key Takeaways

  • The patent's broad independent claims likely extend protection over a wide range of derivatives or methods, providing significant market control.
  • Its strategic value depends on maintaining claim validity amidst Brazil’s rigorous patent examination and opposition processes.
  • Stakeholders should conduct comprehensive freedom-to-operate analyses in light of existing patents and patent applications.
  • Expanding patent protection via divisional or continuation filings can reinforce long-term exclusivity.
  • Vigilant monitoring of legal status and potential challenges ensures effective enforcement and maximizes value extraction.

FAQs

1. What is the primary focus of Brazilian Patent BR112012012406?
It covers [specify, e.g., a novel pharmaceutical compound, formulation, or therapeutic method], aiming to secure exclusive rights over this innovation within Brazil.

2. How broad are the claims in this patent?
The independent claims are formulated to encompass [general structural features or methods], with dependent claims providing particular embodiments, suggesting a broad protective scope.

3. How does this patent relate to international filings?
It may correspond to or be influenced by [e.g., PCT applications, patents in US or Europe], with the local patent potentially complementing or expanding upon international claims.

4. What risks exist for patent infringement?
Competitors may challenge the patent's validity or design around its claims; proactive monitoring and validity assessments are vital.

5. How can owners leverage this patent in Brazil?
The patent enables market exclusivity, licensing opportunities, and potential litigation strategies to deter competitors.


References

[1] Brazilian Patent Office (INPI) Public Records.
[2] Patent examination reports and legal status updates.
[3] Global patent family databases (e.g., WIPO PATENTSCOPE).
[4] Relevant industry patent filings and prior art references.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.